FDA Allows Emergency Use Of Investigational Plasma, Antibody Injections

By Beth Wang / March 24, 2020 at 6:32 PM
FDA is allowing emergency use of investigational convalescent plasma, which involves using plasma collected from recovered COVID-19 patients as a potential therapy for the novel coronavirus disease. The agency on Tuesday (March 24) published a webpage with more information for health care providers interested in getting permission to collect and use plasma under a single patient emergency investigational new drug application. At the same time, the agency authorized the New York State Department of Health to use convalescent plasma. The...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.